Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: An analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)

Leukemia

Volumn 21, Issue 12, 2007, Pages 2463-2469

  Wessendorf, S ^a   Barth, T F E ^b   Viardot, A ^a   Mueller, A ^b   Kestler, H A ^b   Kohlhammer, H ^a   Lichter, P ^c   Bentz, M ^d   Dohner H ^a   Moller P ^b   Schwaenen, C ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; STAT PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BASE PAIRING; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 18Q; CHROMOSOME 2P; CHROMOSOME 6P; CHROMOSOME 7Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME MAP; CHROMOSOME NUMBER; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDIASTINUM CANCER; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

EID: 36349002280     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404919     Document Type: Article

References (37)

1. Jaffe ES, Harris NL, Stein H, Vardman JW (eds). Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001, pp 174-176.
2. Barth TF, Leithauser F, Joos S, Bentz M, Moller P. Mediastinal (thymic) large B-cell lymphoma: Where do we stand? Lancet Oncol 2002; 3 229-234.
3. Moller P, Lammler B, Eberlein-Gonska M, Feichter GE, Hofmann WJ, Schmitteckert H et al. Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch A Pathol Anat Histopathol 1986; 409 79-92.
4. Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: A B-cell tumour of probable thymic origin. Histopathology 1986; 10: 379-390.
5. Hofmann WJ, Momburg F, Moller P. Thymic medullary cells expressing B lymphocyte antigens. Hum Pathol 1988; 19: 1280-1287.
6. Moller P, Moldenhauer G, Momburg F, Lammler B, Eberlein-Gonska M, Kiesel S et al. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood 1987; 69: 1087-1095.
7. Kanavaros P, Gaulard P, Charlotte F, Martin N, Ducos C, Lebezu M et al. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. Am J Pathol 1995; 146: 735-741.
8. Moller P, Lammler B, Hermann B, Otto HF, Moldenhauer G Momburg F. The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression. Immunology 1986; 59: 411-417.
9. Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E et al. Primary mediastinal B-cell lymphoma: High frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol 2003; 162: 243-253.
10. Joos S, Otano-Joos MI, Ziegler S, Bruderlein S, du Manoir S, Bentz M et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87: 1571-1578.
11. Bentz M, Barth TF, Bruderlein S, Bock D, Schwerer MJ, Baudis M et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 2001; 30: 393-401.
12. Joos S, Kupper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000; 60: 549-552.
13. Moller P, Hammerling GJ. The role of surface; HLA-A,B,C molecules in tumour immunity. Cancer Surv 1992; 13: 101-127.
14. Chang CC, Campoli M, Ferrone S. HLA class 1 defects in malignant lesions: What have we learned. Keio J Med 2003; 52: 220-229.
15. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851-862.
16. Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: Implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol 2004; 11: 227-238.
17. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102: 3871-3879.
18. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997; 20: 399-407.
19. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207-211.
20. Wessendorf S, Schwaenen C; Kohlhammer H, Kienle D, Wrobel G, Barth TF et al. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 2003; 22: 1425-1429.
21. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent -genomic alterations. Proc Natl Acad Sci USA 2004; 101: 1039-1044.
22. Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberration~ and allows a refined characterization of consensus regions. Blood 2004; 104 795-801.
23. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kestler HA, Schwoerer A et al. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. [published erratum appears in Cancer Res 2004; 64: 6358]. Cancer Res 2004; 64: 4428-4433.
24. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 2003; 36: 361-374.
25. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TFE et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419-2430.
26. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305: 525-528.
27. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949-951.
28. Nacheva E, Dyer MJ, Metivier C, Jadayel D, Stranks G, Morilla R et al. B-cell non-Hodgkin's lymphoma cell line (Karpas 1106) with complex 6anslo cation involving, 18q21.3 but lacking BCL2 rearrangement and expression. Blood 1994; 84: 3422-3428.
29. Feuerhake F, Kutok JL, Monti S, Chen, W, Lacasce AS, Cattoretti G et al. NF(kappa)B activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005; 106: 1392-1399.
30. Weniger MA, Gesk S, Ehrlich S, Martin-Subero JI, Dyer MJ, Siebert R et al. Gains of REL in primary mediastinal, B-cell lymphoma coincide wit6 nuclear accumulation of REL protein. Genes Chromosomes Cancer 2007; 46: 406-415.
31. Weniger MA, Pulford K, Gesk S, Ehrlich S, Banham AH, Lyne C et al. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia 2006; 20: 1880-1882.
32. Nakagawa M, Hosokawa Y, Yonezumi M, Izumiyama K, Suzuki R, Tsuzuki S et al. MALTI contains nuclear export signals and regulates cytoplasmic locarization of BCL10. Blood 2005; 106: 4210-4216.
33. Jordanova ES, Riemersma SA, Philippo, K, Giphart-Gassler M, Schuuring E; Kluin PM. Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell, lymphomas of the testis and the central nervous system. Genes Chromosomes Cancer 2002; 35: 38-48.
34. Roberts RA, Wright G, Rosenwald AR, Jaramillo MA, Grogan TM, Miller TP et al. Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. Blood 2006; 108: 311-318.
35. Melzner I, Bucur AJ, Bruderlein S, Dorsch K, Hasel C, Barth TF et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 2005; 105: 2535-2542.
36. Melzner I, Weniger MA, Bucur AJ, Bruderlein S, Dorsch K, Hasel C et al. Biallelic deletion within 16p13.13 including SOCS-1 in Karpasl 1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein. Int J Cancer 2006; 118: 1941-1944.
37. Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 2007, 109: 271-280.